Nanoemulsion Development Service
Background Our Services Workflow Applications Why Choose Us Related Services FAQs
At Creative Biolabs, we offer comprehensive nanoemulsion development services designed to bridge the gap between complex active pharmaceutical ingredients (APIs) and clinical viability. By leveraging nanometric oil-in-water dispersions, we dramatically enhance bioavailability and stability for diverse therapeutic applications. Creative Biolabs stands as a premier industry partner, combining decades of expertise in lipid nanotechnology to deliver robust, scalable, and custom-engineered nanoemulsion solutions.
Understanding Nanoemulsion Technology
What Are Nanoemulsions?
Nanoemulsions are isotropic, kinetically stable dispersions of two immiscible liquids—typically oil and water—stabilized by an interfacial film of surfactant and co-surfactant molecules. Unlike conventional macroemulsions, these advanced systems feature droplet sizes in the nanometric range (20–200 nm). This ultra-small droplet size creates a massive surface-area-to-volume ratio, which is the primary driver for their superior performance in drug delivery.
Fig. 1 Graphical summary of nanoemulsions in drug delivery.1
Key Components of a Nanoemulsion System
Success in nanoemulsion formulation relies on the precise selection of three core components:
-
The Oil Phase: Determines the drug loading capacity. We utilize long-chain triglycerides (LCT) or medium-chain triglycerides (MCT) based on your API's lipophilicity.
-
Surfactants & Co-Surfactants: Critical for reducing interfacial tension. We carefully select GRAS-listed excipients to ensure biocompatibility and prevent coalescence.
-
The Aqueous Phase: Can be modified with buffers or tonicity adjusters to match physiological conditions.
Versatile Nanoemulsion Architectures
Depending on the phase composition and the intended application, nanoemulsions are categorized into three primary structural types:
-
Oil-in-Water (O/W) Nanoemulsions: The most widely used type for drug delivery. Nanometric oil droplets (containing the hydrophobic API) are dispersed within a continuous aqueous phase. These are ideal for oral and parenteral delivery of poorly water-soluble drugs.
-
Water-in-Oil (W/O) Nanoemulsions: Water droplets dispersed within a continuous oil phase. These systems are frequently utilized in topical formulations (creams and ointments) or to encapsulate hydrophilic actives in a lipophilic environment.
-
Bicontinuous Nanoemulsions: A complex system where micro-domains of oil and water are interdispersed without forming distinct droplets. These structures typically exist at specific surfactant concentrations and are valuable for specialized controlled-release mechanisms.
Why Nanoemulsions Matter in Research
In modern biopharmaceutical research, nanoemulsions are pivotal for overcoming the critical "solubility-bioavailability paradigm." Their unique physicochemical properties offer distinct advantages:
Enhanced Bioavailability
Effectively solubilizing hydrophobic compounds to improve therapeutic uptake.
Payload Protection
Shielding labile drugs (peptides, nucleic acids) from hydrolysis and enzymatic degradation.
Superior Permeation
Facilitating transport across challenging biological barriers, including the blood-brain barrier and mucosal membranes.
Robust Kinetic Stability
Resisting physical separation phenomena like creaming or sedimentation, ensuring long-term product shelf-life.
Precision Nanoemulsion Engineering Services
Creative Biolabs provides a modular, end-to-end service platform. We don't just formulate; we engineer solutions using Quality by Design (QbD) principles to meet your specific Target Product Profile (TPP).
-
Pre-Formulation Screening: Solubility profiling of your API in various oils and surfactants to construct pseudo-ternary phase diagrams.
-
Custom Formulation Development: Tailoring of O/W or W/O nanoemulsions using high-energy (homogenization) or low-energy (phase inversion) methods.
-
Surface Engineering: Development of cationic nanoemulsions for nucleic acid delivery or mucoadhesive applications.
-
Lyophilization Optimization: Converting liquid nanoemulsions into solid dosage forms using cryoprotectants for enhanced stability.
Workflow
Applications of Nanoemulsion Technology in Modern Research
Our lipid-based expertise allows us to tailor formulations for a wide spectrum of research applications:
-
Oral Drug Delivery: Enhancing the bioavailability of hydrophobic drugs and promoting lymphatic transport to bypass first-pass metabolism.
-
Parenteral Administration: Creating safe, intravenously injectable formulations that minimize the risk of embolism and toxicity.
-
Dermal & Transdermal Systems: Facilitating the permeation of active ingredients through the stratum corneum for localized or systemic therapy.
-
Vaccine Adjuvants: Utilizing nanoemulsions to boost immune response and antigen stability.
-
Gene Delivery: Protecting nucleic acids (RNA/DNA) from degradation using cationic nanoemulsion carriers.
Why Choose Creative Biolabs for Nanoemulsion Services?
-
Exclusive Lipid Focus: Unlike generalist CROs, we have 20+ years of specialized experience specifically in lipid-based systems (Liposomes, LNPs, Nanoemulsions).
-
Advanced Instrumentation: We utilize industry-standard high-pressure homogenizers and microfluidizers to achieve precise, reproducible particle sizes.
-
Customization Flexibility: We tailor every protocol, offering cationic, anionic, and neutral surface charges to match your biological target.
-
Scalable Processes: Our formulations are designed from day one with scale-up in mind, ensuring a smooth transition from R&D to cGMP manufacturing.
-
Collaborative Partnership: We operate with full transparency, providing regular data reviews and direct access to our scientific team.
Creative Biolabs is dedicated to advancing lipid-based drug delivery through innovation and scientific rigor. Our nanoemulsion development services offer a reliable pathway to overcome solubility challenges and enhance the therapeutic efficacy of your compounds. Whether you are in the early discovery phase or preparing for pre-clinical trials, our team provides the expertise and technology to ensure your success.
Related Services
FAQs
What is the typical particle size you can achieve?
We typically engineer formulations with a mean droplet diameter between 20 nm and 200 nm, with a low Polydispersity Index (PDI < 0.2) to ensure uniformity.
Can you handle high-potency APIs?
Yes. Creative Biolabs' facilities are equipped with appropriate containment isolators and safety protocols to handle potent or cytotoxic compounds safely.
What scale can you produce?
We support projects ranging from small-scale feasibility batches (10–50 mL) up to pilot scale (multiple liters) suitable for pre-clinical toxicology studies.
Reference
-
Chatzidaki, Maria D., and Evgenia Mitsou. "Advancements in nanoemulsion-based drug delivery across different administration routes." Pharmaceutics 17.3 (2025): 337. https://doi.org/10.3390/pharmaceutics17030337. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use